CrushSCI.com
108.9平均天数
91中位天数
40最短天数
260最长天数
752025发文量

Paper Review Records

全部论文审稿周期

16 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

101 天

Sex-related differences in time-to-onset of immune checkpoint inhibitor-related interstitial lung disease: a JADER pharmacovigilance study

作者
Naohito Ide; Minori Yamashita; Miyako Yamashita; Ryusuke Watanabe; Chika Moriya; Rin Yagome; Ken-ichi Sako; Tomoji Maeda展开收起
作者单位
1. Department of Clinical Pharmacology, Nihon Pharmaceutical University展开收起
PDF源文件 DOI 网页
46 天

Time-dependent indirect comparison of enfortumab vedotin plus pembrolizumab and disitamab vedotin plus toripalimab in advanced urothelial carcinoma

作者
Hiroki Tanaka; Hiroshi Fukushima; Wei Chen; Fei Li; Soichiro Yoshida; Yasuhisa Fujii展开收起
作者单位
1. Department of Urology, Institute of Science Tokyo; 2. Department of Urology, Zigong Fourth People’s Hospital; 3. Department of Urology, Nanfang Hospital, Southern Medical University展开收起
PDF源文件 DOI 网页
41 天

Integrative topological and longitudinal transcriptomic analyses identify a 14-gene interferon-stimulated module associated with acquired sunitinib resistance in clear cell renal cell carcinoma

作者
Wenhao Chu; Fuhao Wang; Liangkuan Bi; Xing Fu展开收起
作者单位
1. Department of Urology, the First Affiliated Hospital of Anhui Medical University; 2. Department of Urology, Shenzhen Key Laboratory of Male Reproductive Medicine and Genetics, and Shenzhen Clinical Research Center for Urology and Nephrology, Peking University Shenzhen Hospital; 3. School of Medicine, Southern University of Science and Technology展开收起
PDF源文件 DOI 网页
75 天

Emerging roles of long non-coding RNA CASC2 in tumor chemoresistance – a review

作者
Lingyun Zhou; Jintao He; Wenbing Huang; Zhengliang Li; Min Yu; Jiangyan Li; Wenzhong Yang; Wei Xiong展开收起
作者单位
1. Department of Biochemistry and Molecular Biology, Health Science Center, College of Basic Medical Sciences, Dali University; 2. Key Laboratory of Clinical Biochemistry Testing in Universities of Yunnan Province, Health Science Center, School of Basic Medical Sciences, Dali University; 3. Department of Radiology, The First Affiliated Hospital of Dali University, Dali University; 4. Department of Biochemistry and Molecular Biology, College of Life Sciences, Yunnan University; 5. Department of Surgery, Health Science Center, College of Clinical Medicine, Dali University展开收起
PDF源文件 DOI 网页
57 天

Hepatic arterial infusion chemotherapy plus lenvatinib with or without PD-1 inhibition for unresectable hepatocellular carcinoma: a retrospective cohort study

作者
Haidong Yu; Cunkai Ma; Cairang Yangdan; Haiming Yang; Xiaolei Xu展开收起
作者单位
1. Department of Hepatopancreatobiliary Surgery, The Affiliated Hospital of Qinghai University; 2. Department of Interventional Therapy, The Affiliated Hospital of Qinghai University展开收起
PDF源文件 DOI 网页
77 天

Longitudinal acquisition and infection risk associated with multidrug-resistant organisms and Candida colonization in intensive care unit patients

作者
Ülkü Altoparlak; Hatice Erdoğan; Mine Çelik; Gülden Aksu展开收起
作者单位
1. Department of Medical Microbiology, Haseki Training and Research Hospital; 2. Department of Anesthesiology and Reanimation, Haseki Training and Research Hospital展开收起
PDF源文件 DOI 网页

FAQ

JOURNAL OF CHEMOTHERAPY审稿要多久?

截至2026-11-19,CrushSCI 收录了 JOURNAL OF CHEMOTHERAPY 的 16 篇完整审稿记录。最快一篇从收稿到录用用了 40 天(Combination therapy does not decrease 30-day mortality but increases antibiotic consumption in methicillin-sensitive S. aureus bacteraemia,2025-07-18 收稿,2025-08-27 录用),最慢一篇用了 260 天;平均 108.9 天,中位数 91 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。